Category: News Coverage

UK biotech signs $1bn deal to develop liver disease drugs

Podcast: Unlock the potential of complex human liver data

UK startups are built on immigrant talent, the UK will fail if it forgets this

Future of liver drugs – better AI or better data?

Ochre Bio: fully human, super speedy liver drug development

Exploring liver disease therapies 

Ochre Bio with CEO/Co-founder Jack O’Meara and liver expert Dr Scott Friedman, Mount Sinai

Revolutionising Liver Transplants: Can Phenotyping Drive Biotech Transformation in Healthcare?

Business of Biotech with Ochre Bio’s Quin Wills, M.D., PH.D

Ochre Bio CEO named on Forbes 30 Under 30 Europe